Skip to main content

Table 2 Association between ERCC2 polymorphisms with oral cancer risks

From: Association between polymorphisms in ERCC2 gene and oral cancer risk: evidence from a meta-analysis

  No of studies Fixed-effect Random-effect Phet I-squared (%)
Rs1799793      
GA vs. GG 3 1.14[0.91,1.43] 1.13[0.80,1.61] 0.182 41.2
AA vs. GG 3 1.27[0.87,1.86] 1.24[0.87,1.85] 0.436 0.0
GA + AA vs. GG 3 1.16[0.94,1.44] 1.17[0.89,1.55] 0.268 24.0
AA vs. GA + GG 3 1.18[0.82,1.70] 1.16[0.81,1.68] 0.406 0.0
A vs. G 3 1.13[0.96,1.34] 1.13[0.96,1.34] 0.491 0.0
Rs13181      
AC vs. AA 6 1.16[0.96,1.40] 1.17[0.90,1.51] 0.171 35.5
CC vs. AA 6 1.42[1.03,1.96] 1.71[0.92,3.20] 0.044 56.1
AC + CC vs. AA 6 1.19[1.00,1.43] 1.24[0.92,1.67] 0.045 55.8
CC vs. AC + AA 6 1.29[0.95,1.76] 1.48[0.87,2.52] 0.101 45.7
C vs. A 6 1.17[1.02,1.34] 1.23[0.94,1.62] 0.011 66.1
  1. Phet: P value for heterogeneity test.